COVID-19 at-home test kits are in short supply; 2021 is on track to surpass 2020's death toll; hospitals report patient surges.
The unprecedented demand for at-home COVID-19 test kits ahead of the 2021 holiday season has led major pharmacy chains Walgreens and CVS to ration individual purchases, USA Today reports. At Walgreens, customers are limited to purchasing 4 home test kits, while at CVS, that limit is set at 6. Some stores may say they’re out of stock online while in-person stock is available in some communities. Yesterday, President Joe Biden announced his administration will mail 500 million at-home test kits for free in January.
According to the Associated Press, health officials say 2021 is on track to be even more deadly than 2020 in the United States. It will still be weeks before accurate death counts from November and December are processed, but publicly available information indicates this year’s death toll is likely to surpass that of 2020 by at least 15,000. Last year was the deadliest in the nation’s history, due in large part to the COVID-19 pandemic, and updated data show that figures are worse than what the CDC previously reported. Life expectancy in 2020 also fell by 1.8 years compared with 2019.
Hospitals around the country are struggling with the latest increase in COVID-19 cases fueled by the Omicron variant and the still-present Delta variant, NBC News reports. An ongoing shortage of personnel is also complicating matters, and The New York Times reports that 2 of the 3 monoclonal antibodies doctors have depended on to treat COVID-19 patients do not seem as effective against the Omicron variant. The remaining seemingly effective treatment is now in short supply. However, according to The Washington Post, new data indicate early use of convalescent plasma could help prevent infections with the Omicron variant from becoming severe.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More